VXRT - Vaccine pill could help overcome COVID-19 vaccine resistance; Vaxart up 7%

A new poll, commissioned by Vaxart (VXRT), found that 70% would prefer a vaccine given as a pill than an injection.While 23% of respondents said they didn't plan on getting a COVID-19 vaccine, about one-third said they would if given the option of a vaccine pill.The national survey included 1,500 adults.Vaxart recently completed phase 1 of its oral vaccine candidate, VXA-CoV2-1.However, preliminary phase 1 results were disappointing.Vaxart shares are up 7.2% to $5.97.

For further details see:

Vaccine pill could help overcome COVID-19 vaccine resistance; Vaxart up 7%